Ï㽶ÊÓƵ

Richard S. Lemons
No Rating Available
(Learn About Our Rating System)

Richard S. Lemons, MD, PhD

Languages spoken: English

Clinical Locations

Primary Children's Hospital

Pediatric Hematology/Oncology
Salt Lake City
801-662-4700

  • Richard Lemons, MD, PhD, is a professor in the Department of Pediatrics at the Ï㽶ÊÓƵ of Utah School of Medicine, medical director and chief of pediatric hematology/oncology at Primary Children's Medical Center and the Ï㽶ÊÓƵ of Utah, and a Huntsman Cancer Institute investigator. He is involved in various clinical trials for pediatric malignancies and pediatric hematologic disorders.

    Lemons earned a medical degree from George Washington Ï㽶ÊÓƵ School of Medicine, Washington, DC; and performed an internship and residency at Johns Hopkins Hospital, Baltimore. Lemons was a staff member at St. Jude Children's Research Hospital prior to joining the Ï㽶ÊÓƵ of Utah Department of Pediatrics. He is board certified in Pediatrics and Pediatric Hematology-Oncology.

    Specialties

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)

  • Richard Lemons, MD, PhD, is a professor in the Department of Pediatrics at the Ï㽶ÊÓƵ of Utah School of Medicine, medical director and chief of pediatric hematology/oncology at Primary Children's Medical Center and the Ï㽶ÊÓƵ of Utah, and a Huntsman Cancer Institute investigator. He is involved in various clinical trials for pediatric malignancies and pediatric hematologic disorders.

    Lemons earned a medical degree from George Washington Ï㽶ÊÓƵ School of Medicine, Washington, DC; and performed an internship and residency at Johns Hopkins Hospital, Baltimore. Lemons was a staff member at St. Jude Children's Research Hospital prior to joining the Ï㽶ÊÓƵ of Utah Department of Pediatrics. He is board certified in Pediatrics and Pediatric Hematology-Oncology.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Academic Divisions Hematology/Oncology
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)

    Education history

    Certification Conflict Mediation - Ï㽶ÊÓƵ of Utah Postgraduate Certificate
    NRSA Tumor Cell Biology - St. Jude Children's Research Hospital Fellow
    Residency Pediatrics - Johns Hopkins Hospital Resident
    Cancer Bio Research - National Institutes of Health Fellow
    Professional Medical Medicine - George Washington Ï㽶ÊÓƵ M.D.
    Genetics - National Institutes of Health Postdoctoral Fellow
    Doctoral Training Chemistry - Pennsylvania State Ï㽶ÊÓƵ Ph.D.
    Ï㽶ÊÓƵ of Connecticut B.A.

    Selected Publications

    Journal Article

    1. Lemons R, Wang M, Curtin J, Lepatan LM, Male C, Peyvandi F, von Depka Prondzinski M, Wang R, McKeand W, Seifert W, Oldenburg J (2024). Safety and Efficacy of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Untreated Patients with Hemophilia B. TH Open, 8(1), e155-e163. ()
    2. Constance JE, McFarland MM, Casucci T, Deininger MW, Enioutina EY, Job K, Lemons RS, Lim CS, Ward RM, Yellepeddi V, Watt KM (2023). Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping Review. JMIR Res Protoc, 12, e38167. ()
    3. Pipe SW, Leebeek FWG, Recht M, Key NS, Castaman G, Miesbach W, Lattimore S, Peerlinck K, Van der Valk P, Coppens M, Kampmann P, Meijer K, OConnell N, Pasi KJ, Hart DP, Kazmi R, Astermark J, Hermans CRJR, Klamroth R, Lemons R, Visweshwar N, von Drygalski A, Young G, Crary SE, Escobar M, Gomez E, Kruse-Jarres R, Quon DV, Symington E, Wang M, Wheeler AP, Gut R, Liu YP, Dolmetsch RE, Cooper DL, Li Y, Goldstein B, Monahan PE (2023). Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B. N Engl J Med, 388(8), 706-718. ()
    4. Biltaji E, Enioutina EY, Yellepeddi V, Rower JE, Sherwin CMT, Ward RM, Lemons RS, Constance JE (2020). Supportive care medications coinciding with chemotherapy among children with hematologic malignancy. Leuk Lymphoma, 61, 1-12. ()
    5. Olson J, Mehra S, Hersh AL, Thorell EA, Stoddard GJ, Maese L, Barnette PE, Lemons RS, Pavia AT, Knackstedt ED (2020). Oral Step-Down Therapy With Levofloxacin for Febrile Neutropenia in Children With Cancer. J Pediatric Infect Dis Soc, 10(1), 27-33. ()
    6. Kaul S, Korgenski EK, Ying J, Ng CF, Smits-Seemann RR, Nelson RE, Andrews S, Raetz E, Fluchel M, Lemons R, Kirchhoff AC (2015). A retrospective analysis of treatment-related hospitalization costs of pediatric, adolescent, and young adult acute lymphoblastic leukemia. Cancer Med, 5(2), 221-9. ()
    7. Grainger JD, Locatelli F, Chotsampancharoen T, Donyush E, Pongtanakul B, Komvilaisak P, Sosothikul D, Drelichman G, Sirachainan N, Holzhauer S, Lebedev V, Lemons R, Pospisilova D, Ramenghi U, Bussel JB, Bakshi KK, Iyengar M, Chan GW, Chagin KD, Theodore D, Marcello LM, Bailey CK (2015). Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial. Lancet, 386(10004), 1649-58. ()
    8. Lowichik A, Zhou H, Pysher TJ, Smith L, Lemons R, Coffin CM (2000). Therapy associated changes in childhood tumors. Adv Anat Pathol, 7(6), 341-59. ()
    9. Morgan R, Riske CB, Meloni A, Ries CA, Johnson CH, Lemons RS, Sandberg AA (1991). t(16;21)(p11.2;q22): a recurrent primary rearrangement in ANLL. Cancer Genet Cytogenet, 53(1), 83-90. ()